rate increased after RYGB to 28% at 1 year (21 patients), 31% at 5 years (23 patients), and 47% at 10 years (35 patients) (Figure 1) .
ASSOCIATION OF VA SURGEONS

Prophylactic Ureteral Stent Placement vs No Ureteral Stent Placement During Open Colectomy
The prophylactic placement of ureteral stents during colorectal surgery may facilitate ureteral identification and/or recognition of injury. Patients with a planned ureteral resection to achieve a negative oncologic margin were excluded (n = 3). The Charlson comorbidity index with age adjustment, a validated measure of perioperative mortality, was calculated and used for risk stratification. 5 The primary outcomes of ureteral injury were compared between patients who underwent colectomy with ureteral stent placement and patients who underwent colectomy without ureteral stent placement. Secondary outcomes of length of stay, in-hospital mortality, procedural duration, and new-onset urinary complication (hematuria, dysuria, or urinary tract infection in the postoperative period) were also compared. The Yale Human Investigation Committee approved this study with waiver of patient consent. Multivariable logistic regression models were created to analyze factors associated with each outcome by a backward elimination technique with a significance threshold for inclusion in the final model of P < .10. Use of ureteral stents was forced into all models to determine the association of prophylactic stenting with each outcome. All analyses were performed using SAS, version 9.4 (SAS Institute Inc). P < .05 was considered significant. . One ureteral injury occurred (0.3%) in a patient who had stents placed. This injury was noted after the procedure, and the patient required reoperation. When accounting for the age-adjusted Charlson comorbidity index, procedural indication, sex, body mass index, emergency vs elective status, and extent of resection (right, left, or total colectomy), we found that there was no difference in mean (SD) hospital length of stay (11.8 [9.5] days vs 13.1 [13.3] days; P = .49) and in-hospital mortality (1 [1.9%] vs 34 [10.6%]; P = .5) between patients with stenting and patients without stenting ( Table 2 ). There was a trend toward longer operative times with stenting (an additional 55 minutes; P = .16), which may in part be due to the time needed to place stents. Patients who received stents had higher rates of new-onset urinary complications (odds ratio, 4.29; 95% CI, 1.83-10.06; P < .001).
Discussion | In this cohort of 374 patients undergoing open colectomy, prophylactic ureteral stenting was associated with increased operative times and increased rates of postoperative urinary complications. Although the overall rate of ureteral injury was low (0.3%) compared with other studies, the only injury occurred in a patient who received prophylactic ureteral stents.
Injury to the ureter is a serious complication in colorectal surgery, with a reported incidence of 0.2% to 7.6%, and the use of prophylactic ureteric stents remains controversial.
6 Although some surgeons advocate for routine use of stents, others use stents selectively in patients with large tumors, prior radiotherapy or pelvic surgery, chronic inflammatory disease, or urologic pathologic conditions. 1,2,6 Although the advantage of using stents to aid in ureteral identification and facilitate early repair of ureteral injuries is theorized, this study suggests that these benefits may not be realized for patients undergoing open colectomy. In addition, the risk of postoperative infection and the resultant increase in hospital costs without significant benefit may call into question the practice of routine stent use. This study may be underpowered, given the rare occurrence of ureteral injury. Prospective multiinstitutional studies should be conducted to fully assess the utility of ureteral stents in open colectomies and to aid in the establishment of practice guidelines. 
